Epilepsy duration is an independent factor for electrocardiographic changes in pediatric epilepsy

See Wai Chan1, Leslie A Dervan2,3, Robert Scott Watson2,4

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

Epilepsia Open
|July 8, 2021
PubMed

Insights

Cardiac alterations are more common in children with longer epilepsy duration. This study found that for every year of epilepsy, the odds of ECG changes increased, suggesting a time-dependent phenomenon in pediatric epilepsy.

Area of Science:

  • Pediatric Cardiology
  • Neurology
  • Epilepsy Research

Background:

  • Cardiac alterations are a potential comorbidity in epilepsy.
  • The relationship between epilepsy duration and cardiac changes is not well understood.
  • This study investigates cardiac alterations as a time-dependent phenomenon in pediatric epilepsy.

Purpose of the Study:

  • To evaluate if cardiac alterations are time-dependent in pediatric epilepsy patients.
  • To assess the association between epilepsy duration and electrocardiogram (ECG) changes.
  • To identify potential cardiac comorbidities in children with epilepsy.

Main Methods:

  • Retrospective analysis of pediatric epilepsy patients without pre-existing cardiac conditions.
  • Inclusion of all available 12-lead ECGs from patients with a history of intensive care unit admission for seizures.
  • Examination of ECGs for changes in rhythm, intervals, axis, morphology, ST segment, or T wave, analyzed using multivariable logistic regression.

Main Results:

  • 53% of ECGs showed alterations, with 65% of children having at least one altered ECG.
  • Epilepsy duration was independently associated with altered ECGs (OR: 1.1 per year, P = .002).
  • Children with 10 and 15 years of epilepsy duration had 2.9 and 4.9 times the odds of ECG changes, respectively.

Conclusions:

  • Cardiac alterations may increase with epilepsy duration in pediatric patients.
  • Further research is needed to understand the clinical implications and generalizability of these findings.
  • Epilepsy duration is a significant factor in the development of cardiac alterations in children.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
505
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
824
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
47
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
381
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
550
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
4.2K